These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18981458)

  • 1. Temsirolimus in patients with renal cancer on hemodialysis.
    Lunardi G; Vannozzi MO; Armirotti A; Nicodemo M; Venturini M; Cavallini L
    J Clin Oncol; 2008 Dec; 26(34):5652-3; author reply 5653-4. PubMed ID: 18981458
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
    Lunardi G; Armirotti A; Nicodemo M; Cavallini L; Damonte G; Vannozzi MO; Venturini M
    Clin Ther; 2009 Aug; 31(8):1812-9. PubMed ID: 19808140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour flare during interruption of temsirolimus treatment for metastatic renal cell cancer.
    Paterson C; Jones RJ
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):732-3. PubMed ID: 19665360
    [No Abstract]   [Full Text] [Related]  

  • 4. Temsirolimus (Torisel) for advanced renal cell carcinoma.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):103-4. PubMed ID: 18084154
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus in metatastic renal cell carcinoma.
    Brugarolas J; Lotan Y; Watumull L; Kabbani W
    J Clin Oncol; 2008 Jul; 26(20):3457-60. PubMed ID: 18612163
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
    Gerullis H; Bergmann L; Maute L; Eimer C; Otto T
    Cancer Chemother Pharmacol; 2009 May; 63(6):1097-102. PubMed ID: 18818922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progression of late metastases of renal cell carcinoma].
    Wittekind C
    Dtsch Med Wochenschr; 2006 Apr; 131(17):994. PubMed ID: 16673224
    [No Abstract]   [Full Text] [Related]  

  • 8. Temsirolimus for advanced renal-cell carcinoma.
    Ferretti G
    N Engl J Med; 2007 Sep; 357(10):1050; author reply 1050-1. PubMed ID: 17823993
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial experience with temsirolimus in 2nd-, 3rd- and 4th-line therapy for metastatic renal cell cancer: good clinical response.
    Kuru TH; Huber J; Hatiboglu G; Wagener N; Pahernik S; Hadaschik B; Hohenfellner M
    Urol Int; 2011; 86(3):256-60. PubMed ID: 21266794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis.
    Miyake H; Harada K; Kusuda Y; Fujisawa M
    Int J Clin Oncol; 2013 Dec; 18(6):1054-9. PubMed ID: 23114786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temsirolimus in renal cell carcinoma.
    Otto T; Eimer C; Gerullis H
    Transplant Proc; 2008 Dec; 40(10 Suppl):S36-9. PubMed ID: 19100905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temsirolimus for advanced renal cell carcinoma.
    Figlin RA
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):893. PubMed ID: 18185488
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.
    Jafri M; Douis H; Porfiri E
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):657-8. PubMed ID: 18644704
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mammalian target of rapamycin, its mode of action and clinical response in metastatic clear cell carcinoma].
    Shuuin T; Karashima H
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1076-9. PubMed ID: 19620795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temsirolimus as base immunosuppressant for a recipient with metastatic renal cancer: adequate immunosuppression and oncological control--case report.
    Chueh SJ; Sankari BR; Gonzales-Chambers R; Lipscomb L; Africa J; Williams J; Jones AM
    Transplant Proc; 2014; 46(1):271-3. PubMed ID: 24507065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of renal cell carcinoma metastatic to the nose and tongue.
    Lang EE; Patil N; Walsh RM; Leader M; Walsh MA
    Ear Nose Throat J; 2003 May; 82(5):382-3. PubMed ID: 12789766
    [No Abstract]   [Full Text] [Related]  

  • 17. Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.
    Oudard S; Medioni J; Aylllon J; Barrascourt E; Elaidi RT; Balcaceres J; Scotte F
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):705-17. PubMed ID: 19496707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endobronchial metastases from renal cell carcinoma: a late manifestation of the disease with an increasing incidence.
    Khattak MA; Fisher RA; Pickering LM; Gore ME; Larkin JM
    BJU Int; 2012 Nov; 110(10):1407-8. PubMed ID: 22937754
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of untreated renal masses.
    Crispen PL; Uzzo RG
    BJU Int; 2007 May; 99(5 Pt B):1203-7. PubMed ID: 17441911
    [No Abstract]   [Full Text] [Related]  

  • 20. Temsirolimus-induced glomerulopathy.
    Izzedine H; Boostandoot E; Spano JP; Bardier A; Khayat D
    Oncology; 2009; 76(3):170-2. PubMed ID: 19212144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.